Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)

This study has been completed.
Sponsor:
Collaborator:
Muscular Dystrophy Association
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00107770
First received: April 7, 2005
Last updated: January 8, 2010
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)